Mark B. Juckett, MD

home / authors / mark-b-juckett-md

Articles

Mark Juckett, MD, professor, medicine, Division of Hematology, Oncology, and Transplantation, the University of Minnesota Medical School

Dr Juckett on the Evolving Treatment Paradigm in Relapsed/Refractory AML

Mark B. Juckett, MD
July 18th 2024

Mark Juckett, MD, discusses ways the treatment paradigm has changed for patients with relapsed/refractory acute myeloid leukemia.

Read More

Hematopoietic Stem Cell Transplant: A Viable Option for Older Patients With AML

Hematopoietic Stem Cell Transplant: A Viable Option for Older Patients With AML

Mark B. Juckett, MD
March 28th 2020

The challenge in caring for older patients is developing a risk-adapted strategy that best meets the patients’ identified goals and accounts for a realistic assessment of hematopoietic stem cell transplantation suitability.

Read More

Latest Updated Articles

Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors
Published: August 22nd 2024 | Updated: August 29th 2024
Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors
Long-term Follow-up of Selinexor Maintenance for Patients With TP53wt Advanced or Recurrent Endometrial Cancer: A Prespecified Subgroup Analysis From the Phase 3 ENGOT-EN5/GOG-3055/SIENDO Study
Published: August 6th 2024 | Updated: August 19th 2024
Long-term Follow-up of Selinexor Maintenance for Patients With TP53wt Advanced or Recurrent Endometrial Cancer: A Prespecified Subgroup Analysis From the Phase 3 ENGOT-EN5/GOG-3055/SIENDO Study
Sarwish Rafiq, PhD
Published: July 9th 2024 | Updated: July 10th 2024
Dr Rafiq on Novel Strategies for CAR T-Cell Engineering in Solid Tumors
Jens Hoeppner, FAChirg, FACS, MD
Published: June 2nd 2024 | Updated: June 3rd 2024
Perioperative Chemotherapy Prolongs OS vs Neoadjuvant Chemoradiation in Esophageal Cancer
Caroline Robert, MD, PhD
Published: September 15th 2024 | Updated: September 19th 2024
Long-Term KEYNOTE-006 Data Support Pembrolizumab as SOC in Advanced Melanoma
Sameh Gaballa, MD
Published: August 19th 2024 | Updated: September 19th 2024
Case Studies: Three follicular lymphoma cases treated with oral tazemetostat